NASDAQ: CCCCC4 Therapeutics Inc Stock Ownership - Who owns C4 Therapeutics?
Insider buying vs selling
Have C4 Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Leonard Reyno | Chief Medical Officer | 2026-01-16 | 10,000 | $2.22 | $22.20kSell |
| Kenneth Carl Anderson | Director | 2026-01-02 | 5,958 | $1.93 | $11.50kBuy |
| Donna Roy Grogan | Director | 2026-01-02 | 7,513 | $1.93 | $14.50kBuy |
| Paige Mahaney | Chief Scientific Officer | 2025-10-28 | 5,644 | $2.58 | $14.56kSell |
| Donna Roy Grogan | Director | 2025-10-01 | 6,740 | $2.15 | $14.49kBuy |
| Kenneth Carl Anderson | Director | 2025-10-01 | 5,349 | $2.15 | $11.50kBuy |
| Kendra Adams | Chief Financial Officer | 2025-09-18 | 2,775 | $3.32 | $9.21kSell |
| Leonard Reyno | Chief Medical Officer | 2025-07-10 | 7,382 | $1.99 | $14.69kSell |
| Leonard Reyno | Chief Medical Officer | 2025-07-10 | 7,382 | $1.99 | $14.69kSell |
| Leonard Reyno | Chief Medical Officer | 2025-07-10 | 7,382 | $1.99 | $14.69kSell |
CCCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CCCC insiders and whales buy or sell their stock.
CCCC Shareholders
What type of owners hold C4 Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Marc A. Cohen | 8.57% | 8,308,874 | $15.21M | Insider |
| Lynx1 Capital Management LP | 7.32% | 7,098,133 | $12.99M | Institution |
| Soleus Capital Management LP | 7.28% | 7,053,942 | $12.91M | Institution |
| Alain J. Cohen | 6.29% | 6,094,001 | $11.15M | Insider |
| Orbimed Advisors LLC | 5.40% | 5,235,146 | $9.58M | Institution |
| Morgan Stanley | 5.13% | 4,972,032 | $9.10M | Institution |
| Wasatch Advisors LP | 5.01% | 4,852,741 | $8.88M | Institution |
| Vanguard Group Inc | 3.29% | 3,191,557 | $5.84M | Institution |
| Bank Of America Corp | 2.12% | 2,053,162 | $3.76M | Institution |
| Millennium Management LLC | 2.00% | 1,934,225 | $3.54M | Institution |
CCCC vs Biotech Stocks
C4 Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.